Inogen Inc (NASDAQ:INGN) CFO Alison Bauerlein sold 11,718 shares of the stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $115.87, for a total transaction of $1,357,764.66. Following the completion of the sale, the chief financial officer now directly owns 11,718 shares of the company’s stock, valued at $1,357,764.66. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Alison Bauerlein also recently made the following trade(s):
- On Monday, February 12th, Alison Bauerlein sold 27,630 shares of Inogen stock. The stock was sold at an average price of $116.46, for a total transaction of $3,217,789.80.
Inogen Inc (INGN) traded up $0.49 during trading hours on Tuesday, reaching $117.90. The company had a trading volume of 123,377 shares, compared to its average volume of 133,449. Inogen Inc has a 12-month low of $66.51 and a 12-month high of $130.05. The firm has a market capitalization of $2,460.00, a P/E ratio of 82.45, a P/E/G ratio of 3.96 and a beta of 1.02.
A number of analysts have recently issued reports on the stock. BidaskClub raised shares of Inogen from a “hold” rating to a “buy” rating in a research report on Saturday. Zacks Investment Research lowered shares of Inogen from a “buy” rating to a “hold” rating in a research report on Wednesday, February 7th. Needham & Company LLC increased their price target on shares of Inogen from $108.00 to $125.00 and gave the stock a “strong-buy” rating in a research report on Wednesday, November 8th. Finally, Leerink Swann reissued an “outperform” rating and issued a $120.00 price target (up from $115.00) on shares of Inogen in a research report on Wednesday, November 8th. Three analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Inogen presently has a consensus rating of “Buy” and a consensus target price of $103.14.
COPYRIGHT VIOLATION WARNING: “Inogen Inc (INGN) CFO Alison Bauerlein Sells 11,718 Shares” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/02/13/inogen-inc-ingn-cfo-alison-bauerlein-sells-11718-shares.html.
Inogen Company Profile
Inogen, Inc is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device.
Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter.